Changes in the signal- and contrast-to-noise ratios of hepatocellular carcinomas on gadoxetic acid-enhanced dynamic MR imaging

European Journal of Radiology

Volumn 82, Issue 1, 2013, Pages 62-68

  Kim, Hyun Su ^a   Choi, Dongil ^a   Kim, Seong Hyun ^a   Lee, Min Woo ^a   Lee, Won Jae ^a   Kim, Young Kon ^a   Jang, Kyung Mi ^a   Park, Min Jung ^a   Park, Cheol Keun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CNR; Enhanced MRI; Gadoxetic acid; Hepatocellular carcinoma; SNR

Indexed keywords

GADOXETIC ACID;

ADULT; ARTERY; ARTICLE; CANCER GRADING; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; FEMALE; HUMAN; IMAGING; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO;

EID: 84871716758     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.05.036     Document Type: Article

References (21)

1. C. Bartolozzi, L. Crocetti, R. Lencioni, D. Cioni, C. Della Pina, and D. Campani Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media European Radiology 17 2007 2519 2530
2. S.H. Kim, J. Lee, and M.J. Kim Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma American Journal of Roentgenology 192 2009 1675 1681
3. T.J. Vogl, S. Kummel, and R. Hammerstingl Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 1996 59 67
4. J.E. van Montfoort, B. Stieger, D.K. Meijer, H.J. Weinmann, P.J. Meier, and K.E. Fattinger Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1 Journal of Pharmacology and Experimental Therapeutics 290 1999 153 157
5. V. Lorusso, L. Pascolo, C. Fernetti, M. Visigalli, P. Anelli, and C. Tiribelli In vitro and in vivo hepatic transport of the magnetic resonance imaging contrast agent B22956/1: role of MRP proteins Biochemical and Biophysical Research Communications 293 2002 100 105
6. A. Kitao, Y. Zen, and O. Matsui Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging - correlation with molecular transporters and histopathologic features Radiology 256 2010 817 826
7. P. Reimer, E.J. Rummeny, and K. Shamsi Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 1996 177 183
8. A. Huppertz, S. Haraida, and A. Kraus Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations Radiology 234 2005 468 478
9. M. Hayashi, O. Matsui, and K. Ueda Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium American Journal of Roentgenology 172 1999 969 976
10. M. Kadoya, O. Matsui, T. Takashima, and A. Nonomura Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings Radiology 183 1992 819 825
11. S.C. Efremidis, P. Hytiroglou, and O. Matsui Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges European Radiology 17 2007 2969 2982
12. K. Nasu, Y. Kuroki, T. Tsukamoto, H. Nakajima, K. Mori, and M. Minami Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade American Journal of Roentgenology 193 2009 438 444
13. S.H. Heo, Y.Y. Jeong, and S.S. Shin Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor Korean Journal of Radiology 11 2010 295 303
14. S.S. Ahn, M.J. Kim, J.S. Lim, H.S. Hong, Y.E. Chung, and J.Y. Choi Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma Radiology 255 2010 459 466
15. A. Huppertz, T. Balzer, and A. Blakeborough Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings Radiology 230 2004 266 275
16. M. Kinoshita, and M. Miyata Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci Hepatology 36 2002 433 438
17. G. Marchal, X. Zhang, Y. Ni, P. Van Hecke, J. Yu, and A.L. Baert Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology Magnetic Resonance Imaging 11 1993 665 674
18. J.L. Chezmar, R.D. Redvanly, and C.W. Sewell Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features Academic Radiology 3 Suppl. 2 1996 S413 S414
19. M. Narita, E. Hatano, and S. Arizono Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma Journal of Gastroenterology 44 2009 793 798
20. W. Stern, F. Schick, and A.F. Kopp Dynamic MR imaging of liver metastases with Gd-EOB-DTPA Acta Radiologica 41 2000 255 262
21. B.B. Frericks, C. Loddenkemper, and A. Huppertz Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA American Journal of Roentgenology 193 2009 1053 1060